Health Care Distributors

TYCOON GROUP

TYCOON GROUP released FY2025 Q1 earnings on August 29 (BJT), actual revenue HKD 255.04 M, actual EPS HKD -0.005

TYCOON GROUP released FY2025 Q2 earnings on August 29 During-Market (BJT), actual revenue HKD 255.04 M, actual EPS HKD -0.0049

TYCOON GROUP released FY2025 Semi-Annual earnings on August 29 During-Market (BJT), actual revenue HKD 510.08 M, actual EPS HKD -0.0098

TYCOON GROUP to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT)

Man Guan Group Proposes Share Issuance to Enhance Financial Flexibility

Jacobsen Scientific Pharmaceutical Increases Holding in Full Circle Group

Man Kwong Group Raises HK$46.7 Million Through Share Issuance

Man Wah Group's Stock Price Rallies After Plunge

Manwan Group's Stock Plummets to New Low

TYCOON GROUP released FY2024 9 Months Earnings on March 28 (BJT), with actual revenue of 655.52 M HKD and EPS of 0.014 HKD

TYCOON GROUP released FY2024 Q3 earnings on March 28 (BJT), actual revenue 220.51 M HKD, actual EPS -0.0129 HKD

TYCOON GROUP released FY2024 Q4 earnings on March 28 After-Market (BJT), actual revenue 220.51 M HKD, actual EPS -0.0129 HKD

TYCOON GROUP released FY2024 annual earnings on March 28 After-Market (BJT), actual revenue 876.04 M HKD, actual EPS 0.004 HKD

TYCOON GROUP FY2024 Annual Earnings Release on March 28, After-Market BJT

Man Kwan Group's Pre-Tax Profit Declines Significantly in Fiscal Year 2024

Wang Jiajun Increased Holdings in Full Champion Group by 362,000 Shares, Total Amount Approximately HKD 1.2381 Million

Man Guo Group Releases Mid-Year Results for 2024

Man Guan Group announces performance forecast for the first half of 2024

Man Guan Group releases 2023 annual performance

Tycoon Group released FY2020 Q3 earnings on March 26, 2021 (BJT) with revenue of 161.18M HKD and EPS of -0.0081

PERFECT OPT

SEYOND W30

CH ENV TECH&BIO

REM GROUP HLDGS

BONJOUR HOLD

MODERN LAND

CYBERNAUT INT'L

AFFLUENT FDN

TATA HEALTH

CENTURY GP INTL

藥師幫

GUANZE MEDICAL

君百延集團

上海醫藥

白雲山

華檢醫療

上海先鋒控股

創美藥業

興科蓉醫藥

金活醫藥集團

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap